Lineage Cell Therapeutics, Inc.: capex
| Value | {"amount": 305000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2015-01-01 – 2015-06-30 |
| Status | current |
| Entity | Lineage Cell Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:43:16.416080+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/011c6fc4-e14d-4d6d-9942-27610e3041c8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001140361-15-030782 · Open the official SEC filing →Retrieved: 2026-08-19T08:43:16.416080+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000876343/capex/2015-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/011c6fc4-e14d-4d6d-9942-27610e3041c8
History
- no predecessors — first report